DexTech Medical AB (XSAT:DEX) Total Assets : kr27.72 Mil (As of Dec. 2024)

View and export this data going back to 2014. Start your Free Trial

What is DexTech Medical AB Total Assets?

DexTech Medical AB's Total Assets for the quarter that ended in Dec. 2024 was kr27.72 Mil.

During the past 12 months, DexTech Medical AB's average Total Assets Growth Rate was 7.10% per year. During the past 3 years, the average Total Assets Growth Rate was 45.10% per year. During the past 5 years, the average Total Assets Growth Rate was -6.40% per year. During the past 10 years, the average Total Assets Growth Rate was -7.20% per year.

During the past 12 years, DexTech Medical AB's highest 3-Year average Total Assets Growth Rate was 45.10%. The lowest was -43.20%. And the median was 12.70%.

Total Assets is connected with ROA %. DexTech Medical AB's annualized ROA % for the quarter that ended in Dec. 2024 was -13.52%. Total Assets is also linked to Revenue through Asset Turnover. DexTech Medical AB's Asset Turnover for the quarter that ended in Dec. 2024 was 0.00.

DexTech Medical AB Total Assets Historical Data

The historical data trend for DexTech Medical AB's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DexTech Medical AB Total Assets Chart

DexTech Medical AB Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Total Assets

Get a 7-Day Free Trial

13.34

7.23

39.59

35.03

30.59

DexTech Medical AB Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Total Assets	Get a 7-Day Free Trial															32.80	32.03	30.59	29.16	27.72

DexTech Medical AB Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

DexTech Medical AB's Total Assets for the fiscal year that ended in Jun. 2024 is calculated as

Total Assets	=	Total Equity (A: Jun. 2024 )	+	Total Liabilities (A: Jun. 2024 )
	=	29.608	+	0.98
	=	30.59

DexTech Medical AB's Total Assets for the quarter that ended in Dec. 2024 is calculated as

Total Assets	=	Total Equity (Q: Dec. 2024 )	+	Total Liabilities (Q: Dec. 2024 )
	=	27.507	+	0.211
	=	27.72

DexTech Medical AB (XSAT:DEX) Total Assets Explanation

Total Assets is connected with ROA %.

DexTech Medical AB's annualized ROA % for the quarter that ended in Dec. 2024 is

ROA %	=	Net Income (Q: Dec. 2024 )	/	( (Total Assets (Q: Sep. 2024 )	+	Total Assets (Q: Dec. 2024 ))	/ count )
	=	-3.844	/	( (29.156	+	27.718)	/ 2 )
	=	-3.844	/	28.437
	=	-13.52 %

Note: The Net Income data used here is four times the quarterly (Dec. 2024) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

DexTech Medical AB's Asset Turnover for the quarter that ended in Dec. 2024 is

	Asset Turnover
=	Revenue (Q: Dec. 2024 )	/	( (Total Assets (Q: Sep. 2024 )	+	Total Assets (Q: Dec. 2024 ))	/ count )
=	0	/	( (29.156	+	27.718)	/ 2 )
=	0	/	28.437
=	0.00

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

DexTech Medical AB Total Assets Related Terms

Thank you for viewing the detailed overview of DexTech Medical AB's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

DexTech Medical AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » DexTech Medical AB (XSAT:DEX) » Definitions » Total Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

Dag Hammarskjolds Vag 34A, Uppsala, SWE, 752 37

Website

https://www.dextechmedical.com

DexTech Medical AB develops candidate medications with applications within urological oncology, for prostate cancer. Its medication candidates include GuaDex, OsteoDex, and SomaDex, among others. The company conducts operations in medical research with the development of new drug candidates mainly in urological oncology, but also other cancer diseases and for non-malignant diseases. The company has a well built clinical base with valuable specialist expertise from research laboratories and manufacturing to clinical oncology.